Patent classifications
A61K36/69
CHINESE MEDICINE PRESCRIPTION CAPABLE OF TREATING LUNG ADENOCARCINOMA
A Chinese medicine prescription capable of treating lung adenocarcinoma is composed of Polygala tenuifolia Willd, atractylodes macrocephala, angelica sinensis, poria pararadicis, astragalus membranaceus, ziziphus jujaba Mill.var.spinosa, codonopsis pilosula, costustoot, radix glycyrrhizae preparata and fresh ginger, and a pharmaceutical residue is filtered and obtained after a water quenching procedure of the aforementioned herbs to provide a water-quenched medicine soup, and a pharmaceutical residue is filtered and obtained after processing the water-quenched pharmaceutical residue by a liquor quenching procedure to obtain a liquor-quenched medicine soup; and the water-quenched medicine soup and the liquor-quenched medicine soup are mixed. The prescription is capable of triggering cell autophagy and reducing cell growth, expansion and metastasis, so as to achieve the effect of lung adenocarcinoma treatment.
CHINESE MEDICINE PRESCRIPTION CAPABLE OF TREATING LUNG ADENOCARCINOMA
A Chinese medicine prescription capable of treating lung adenocarcinoma is composed of Polygala tenuifolia Willd, atractylodes macrocephala, angelica sinensis, poria pararadicis, astragalus membranaceus, ziziphus jujaba Mill.var.spinosa, codonopsis pilosula, costustoot, radix glycyrrhizae preparata and fresh ginger, and a pharmaceutical residue is filtered and obtained after a water quenching procedure of the aforementioned herbs to provide a water-quenched medicine soup, and a pharmaceutical residue is filtered and obtained after processing the water-quenched pharmaceutical residue by a liquor quenching procedure to obtain a liquor-quenched medicine soup; and the water-quenched medicine soup and the liquor-quenched medicine soup are mixed. The prescription is capable of triggering cell autophagy and reducing cell growth, expansion and metastasis, so as to achieve the effect of lung adenocarcinoma treatment.
THERAPY FOR PROMOTING CELL GROWTH
There is disclosed the use of a composition for promoting neuronal growth of neurons in tissues of the central or peripheral nervous system. There is also disclosed a method for inducing proliferation or differentiation of neuronal cells.
THERAPY FOR PROMOTING CELL GROWTH
There is disclosed the use of a composition for promoting neuronal growth of neurons in tissues of the central or peripheral nervous system. There is also disclosed a method for inducing proliferation or differentiation of neuronal cells.
THERAPY FOR PROMOTING CELL GROWTH
There is disclosed the use of a composition for promoting neuronal growth of neurons in tissues of the central or peripheral nervous system. There is also disclosed a method for inducing proliferation or differentiation of neuronal cells.
COMPOSITION FOR USE AS A DIETARY SUPPLEMENT FOR THE PRODUCTION OF SHORT-CHAIN PEPTIDES IN THE DIGESTIVE TRACT WHICH ARE RELEVANT FOR THE APPEARANCE OF THE SKIN
A composition for use as a dietary supplement for the production of short-chain peptides in the digestive tract which are relevant for the skin appearance is provided, the composition at least includes the components collagen peptides of bovine origin with a molecular mass of 2000 Da on average, which are characterised by a high sequence homology with human collagen type I -1, type I -2 and type III -1 with an overall sequence coverage of greater than 90% for human collagen type I -1 and -2 and an aqueous extract of acerola fruit (Malpighia punicifolia), which in addition to the standardised vitamin C content is characterised by the presence of soluble dietary fibre with a high uronic acid content. The disclosed composition is particularly suitable as a dietary supplement for maintaining healthy skin.
COMPOSITION FOR USE AS A DIETARY SUPPLEMENT FOR THE PRODUCTION OF SHORT-CHAIN PEPTIDES IN THE DIGESTIVE TRACT WHICH ARE RELEVANT FOR THE APPEARANCE OF THE SKIN
A composition for use as a dietary supplement for the production of short-chain peptides in the digestive tract which are relevant for the skin appearance is provided, the composition at least includes the components collagen peptides of bovine origin with a molecular mass of 2000 Da on average, which are characterised by a high sequence homology with human collagen type I -1, type I -2 and type III -1 with an overall sequence coverage of greater than 90% for human collagen type I -1 and -2 and an aqueous extract of acerola fruit (Malpighia punicifolia), which in addition to the standardised vitamin C content is characterised by the presence of soluble dietary fibre with a high uronic acid content. The disclosed composition is particularly suitable as a dietary supplement for maintaining healthy skin.
SPINAL CORD REGENERATION THERAPY
The present disclosure relates to spinal cord regeneration therapy. The disclosure, in one aspect, provides for the administration to a subject with a spinal cord injury of an effective amount of at least the four herbal components polygalae (thin leaf milkwort), astragali (membranous milkvetch), Ligusticum chuanxiong and Angelica sinensis (Chinese angelica), their roots or rhizomes, or extracts thereof. The disclosure, in other aspects, provides in vitro and in vivo methods for determining the effectiveness of drugs, and drug combinations, and the effective amount thereof required for treating a spinal cord injury.
SPINAL CORD REGENERATION THERAPY
The present disclosure relates to spinal cord regeneration therapy. The disclosure, in one aspect, provides for the administration to a subject with a spinal cord injury of an effective amount of at least the four herbal components polygalae (thin leaf milkwort), astragali (membranous milkvetch), Ligusticum chuanxiong and Angelica sinensis (Chinese angelica), their roots or rhizomes, or extracts thereof. The disclosure, in other aspects, provides in vitro and in vivo methods for determining the effectiveness of drugs, and drug combinations, and the effective amount thereof required for treating a spinal cord injury.
COSMETIC COMPOSITION FOR IMPROVING SKIN CONTAINING EXTRACTS OF POLYGALA TENUIFOLIA, ANGELICA DAHURICA AND ELSHOLTZIA SPLENDENS
A composition for improving skin comprising extracts of Polygala tenuifolia, Angelica dahurica and Elsholtzia splendens is described. The composition is excellent in effects of improving skin inflammation, antioxidant effects, antibacterial effects on skin, and skin moisturizing effects, and thus can be used as a cosmetic for improving skin, and further, as a pharmaceutical composition for treating inflammatory skin diseases.